PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway.

Rat / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29698747 ↗2018Reported benefit

Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway.

RatTBIWeight-drop / impact-accelerationSprague-DawleyMale

Model: Weight-drop model of traumatic brain injury

Metformin improved neurological deficit and reduced cerebral oedema and neuronal apoptosis after traumatic brain injury, inhibited microglial activation and lowered TNF-alpha, IL-1beta and IL-6, with reduced NF-kappaB p65 nuclear translocation and ERK1/2 and p38 MAPK phosphorylation.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.